Is there a role for 15-lipoxygenase in atherogenesis?

Biochemical Pharmacology

Volumn 54, Issue 9, 1997, Pages 953-959

  Feinmark, Steven J ^a,b   Cornicelli, Joseph A ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b PFIZER INC   (United States)

Author keywords

Atherosclerosis; Endothelium; Lipoxygenase; Low density lipoprotein; Macrophage; Oxidation

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ENDOTHELIUM; HUMAN; HYPERCHOLESTEROLEMIA; MACROPHAGE; OXIDATION; PRIORITY JOURNAL; REVIEW;

EID: 0030667114     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00135-4     Document Type: Note

References (59)

1. Ross R, The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362: 801-809, 1993.
2. Williams KJ and Tabas I, The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15: 551-561, 1995.
3. Auberbach BJ, Bisgaier CL, Wölle J and Saxena U, Oxidation of low density lipoproteins greatly enhances their association with lipoprotein lipase anchored to endothelial cell matrix. J Biol Chem 271: 1329-1335, 1996.
4. Haberland ME, Fong D and Cheng L, Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241: 215-218, 1988.
5. Ylä-Herttuala S, Rosenfeld ME, Parthasarathy S, Glass CK, Sigal E, Witztum JL and Steinberg D, Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoproteins in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci USA 87: 6959-6963, 1990.
6. Sigal E, Laughton CW and Mulkins M, Oxidation, lipoxygenase, and atherogenesis. Ann NY Acad Sci 714: 211-224, 1994.
7. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL and Steinberg D, Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84: 1086-1095, 1989.
8. Bolgar MS, Yang C-Y and Gaskell SJ, First direct evidence for lipid/protein conjugation in oxidized human low density lipoprotein. J Biol Chem 271: 27999-28001, 1996.
9. Esterbauer H, Schaur RJ and Zollner H, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128, 1991.
10. Yamamoto S, Mammalian lipoxygenases: Molecular and catalytic properties. Prostaglandins Leukot Essent Fatty Acids 35: 219-229, 1989.
11. Ford-Hutchinson AW, Arachidonate 15-lipoxygenase; Characteristics and potential biological significance. Eicosanoids 4: 65-74, 1991.
12. Kühn H, Belkner J, Wiesner R and Brash AR, Oxygenation of biological membranes by the pure reticulocyte lipoxygenase. J Biol Chem 265: 18351-18361, 1990.
13. Kühn H, Belkner J, Suzuki H and Yamamoto S, Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. J Lipid Res 35: 1749-1759, 1994.
14. Belkner J, Wiesner R, Rathman J, Barnett J, Sigal E and Kühn H, Oxygenation of lipoproteins by mammalian lipoxygenases. Eur J Biochem 213: 251-261, 1993.
15. Parthasarathy S, Weiland E and Steinberg D, A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci USA 86: 1046-1050, 1989.
16. Sparrow CP and Olszewski J, Cellular oxidative modification of low density lipoprotein does not require lipoxygenase. Proc Natl Acad Sci USA 89: 128-131, 1992.
17. Jessup W, Darley-Usmar V, O'Leary V and Bedwell S, 5-Lipoxygenase is not essential in macrophage-mediated ox idation of low-density lipoprotein. Biochem J 278: 163-169, 1991.
18. Sun D and Funk CD, Disruption of 12/15-lipoxygenase expression in peritoneal macrophages: Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein. J Biol Chem 271: 24055-24062, 1996.
19. Sparrow CP and Olszewski J, Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J Lipid Res 34: 1219-1228, 1993.
20. Ezaki M, Witztum JL and Steinberg D, Lipoperoxides in LDL incubated with fibroblasts that overexpress 15-lipoxygenase. J Lipid Res 36: 1996-2004, 1995.
21. Benz DJ, Mol M, Ezaki M, Mori-Ito N, Zelán I, Miyanohara A, Friedmann T, Parthasarathy S, Steinberg D and Witztum JL, Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblasts expressing high levels of human 15-lipoxygenase. J Biol Chem 270: 5191-5197, 1995.
22. Hiltunen T, Luoma J, Nikkari T and Ylä-Herttuala S, Induction of 15-lipoxygenase mRNA and protein in early atherosclerotic lesions. Circulation 92: 3297-3303, 1995.
23. Sendobry SM, Cornicelli JA, Welch K, Bocan T, Tait B, Trivedi BK, Colbry N, Dyer RD, Feinmark SJ and Daugherty A, Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties. Br J Pharmacol, in press.
24. Conrad DJ, Kühn H, Mulkins M, Highland E and Sigal E, Specific inflammatory cytokines regulate the expression of monocyte 15-lipoxygenase. Proc Natl Acad Sci USA 89: 217-221, 1992.
25. Cornicelli JA, Welch K, Auberbach BJ, Feinmark SJ and Daugherty A, Mouse peritoneal macrophages contain abundant ω-6 lipoxygenase activity which is independent of interleukin-4. Arterioscler Thromb Vasc Biol 16: 1488-1494, 1996.
26. Nassar CM, Morrow JD, Roberts LJ II, Lakkis FG and Badr KF, Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem 269: 27631-27634, 1994.
27. Henriksson P, Hamberg M and Diczfalusy U, Formation of 15-HETE as a major hydroxyeicosatetraenoic acid in the atherosclerotic vessel wall. Biochim Biophys Acta 834: 271-274, 1985.
28. Simon TC, Makheja AN and Bailey JM, Formation of 15-hydroxyeicosatetraenoic acid (15-HETE) as the predominant eicosanoid in aortas from Watanabe Heritable Hyperlipidemic and cholesterol-fed rabbits. Atherosclerosis 75: 31-38, 1989.
29. Bailey JM, Makheja AN, Lee R and Simon TH, Systemic activation of 15-lipoxygenase in heart, lung, and vascular tissues by hypercholesterolemia: Relationship to lipoprotein oxidation and atherogenesis. Atherosclerosis 113: 247-258, 1995.
30. Ylä-Herttuala S, Luoma J, Viita H, Hiltunen T, Sisto T and Nikkari T, Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J Clin Invest 95: 2692-2698, 1995.
31. Harats D, Kurihara H, Belloni P, Oakley H, Ziober A, Ackley D, Cain G, Kurihara Y, Lawn R and Sigal E, Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter. J Clin Invest 95: 1335-1344, 1995.
32. Harats D, Kurihara H, Levkovitz H and Sigal E, 15-Lipoxygenase overexpression induces atherosclerosis in LDL deficient mice. Proc Eur Atheroscler Soc 66: 26, 1996.
33. Shen J, Kühn H, Petho-Schramm A and Chan L, Transgenic rabbits with the integrated human 15-lipoxygenase gene driven by a lysozyme promoter: Macrophage-specific expression and variable positional specificity of the transgenic enzyme. FASEB J 9: 1623-1631, 1995.
34. Shen J, Hendrick E, Cornhill JF, Zsigmond E, Kim H-S, Kühn H, Guevara NV and Chan L, Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 98: 2201-2208, 1996.
35. Folcik VA, Nivar-Aristy RA, Krajewski LP and Cathcart MK, Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J Clin Invest 96: 504-510, 1995.
36. Kühn H, Belkner J, Zaiss S, Fährenklemper T and Wohlfeil S, Involvement of 15-lipoxygenase in early stages of atherogenesis. J Exp Med 179: 1903-1911, 1994.
37. Lund E, Diczfalusy U and Björkhem I, On the mechanism of oxidation of cholesterol at C-7 in a lipoxygenase system. J Biol Chem 267: 12462-12467, 1992.
38. Samuelsson B, Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 220: 568-575, 1983.
39. Shimizu T and Wolfe LS, Arachidonic acid cascade and signal transduction. J Neurochem 55: 1-15. 1990.
40. Feinmark SJ, Piomelli D, Shapiro E and Schwartz JH, Biologically active metabolites of the 12-lipoxygenase pathway are formed by Aplysia nervous tissue. Ann NY Acad Sci 559: 121-130, 1989.
41. Glasgow WC, Afshari CA, Barrett JC and Eling TE, Modulation of the epidermal growth factor mitogenic response by metabolites of linoleic and arachidonic acid in Syrian hamster embryo fibroblasts. Differential effects in tumor suppressor gene (+) and (-) phenotypes. J Biol Chem 267: 10771-10779, 1992.
42. Glasgow WC and Eling TE, Structure-activity relationship for potentiation of EGF-dependent mitogenesis by oxygenated metabolites of linoleic acid. Arch Biochem Biophys 311: 286-292, 1994.
43. Abe M, Klein M, Steel DJ, Thekkuveettil A, Shapiro E, Schwartz JH and Feinmark SJ, Stereochemistry of the Aplysia neuronal 12-lipoxygenase: Specific potentiation of FMRFamide action by 12(S)-HPETE. Brain Res 683: 200-208, 1995.
44. Rao GN, Alexander RW and Runge MS, Linoleic acid and its metabolites, hydroperoxyoctadecadienoic acids, stimulate c-Fos, c-Jun, and c-Myc mRNA expression, mitogen-activated protein kinase activation, and growth in rat aortic smooth muscle cells. J Clin Invest 96: 842-847, 1995.
45. Rao GN, Baas AS, Glasgow WC, Eling TE, Runge MS and Alexander RW, Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J Biol Chem 269: 32586-32591, 1994.
46. Rao GN, Glasgow WC, Eling TE and Runge MS, Role of hydroperoxyeicosatetraenoic acids in oxidative stress-induced activating protein 1 (AP-1) activity. J Biol Chem 271: 27760-27764, 1996.
47. Eling TE and Glasgow WC, Cellular proliferation and lipid metabolism: Importance of lipoxygenases in modulating epidermal growth factor-dependent mitogenesis. Cancer Metastasis Rev 13: 397-410, 1994.
48. 2 in norepinephrine-induced arachidonic acid release in rabbit aortic smooth muscle cells. J Biol Chem 271: 30149-30157, 1996.
49. 2+/calmodulin-dependent protein kinase II by arachidonic acid and its metabolites. Proc Natl Acad Sci USA 86: 8550-8554, 1989.
50. Stoll LL, Morland MR and Spector AA, 13-HODE increases intracellular calcium in vascular smooth muscle cells. Am J Physiol 266: C990-C996, 1994.
51. Cho Y and Ziboh VA, Expression of protein kinase C isozymes in guinea pig epidermis: Selective inhibition of PKC-β activity by 13-hydroxyoctadecadienoic acid-containing diacylglycerol. J Lipid Res 35: 913-921, 1994.
52. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM and Lusis AJ, Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344: 254-257, 1990.
53. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ and Fogelman AM, Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 87: 5134-5138, 1990.
54. Schwartz D, Andalibi A, Chaverri-Almada L, Berliner JA, Kirchgessner T, Fang Z-T, Tekamp-Olson P, Lusis AJ, Gallegos C, Fogelman AM and Territo MC, Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. J Clin Invest 94: 1968-1973, 1994.
55. Lehr HA, Hübner C, Nolte D, Finckh B, Beisiegel U, Kohlschütter A and Meßmer K, Oxidatively modified human low-density lipoprotein stimulates leukocyte adherence to the microvascular endothelium in vivo. Res Exp Med (Berl) 191: 85-90, 1991.
56. Vora DK, Fang Z-T, Parhami F, Fogelman AM, Territo MC and Berliner JA, P-Selectin induction by MM-LDL and its expression in human atherosclerotic lesions. Circulation 90: I-83, 1994.
57. Sigari F, Barnett J, Hörkkö S, Witztum JL and Reaven PD, Fibroblasts expressing 15-lipoxygenase generate a bioactive, minimally modified low density lipoprotein. Circulation 94: I-400, 1996.
58. Khan BV, Parthasarathy SS, Alexander RW and Medford RM, Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 95: 1262-1270, 1995.
59. Wölle J, Welch K, Devall LJ, Cornicelli JA and Saxena U, Transient overexpression of human 15-lipoxygenase in aortic endothelial cells enhances tumor necrosis factor-induced vascular cell adhesion molecule-1 gene expression. Biochem Biophys Res Commun 220: 310-314, 1996.